Published in J Chromatogr on January 25, 1985
Purification and properties of a new clathrin assembly protein. EMBO J (1986) 1.83
A comparison of four cathepsins (B, L, N and S) with collagenolytic activity from rabbit spleen. Biochem J (1988) 1.29
Protein S binds to and inhibits factor Xa. Proc Natl Acad Sci U S A (1994) 1.25
Preparation and purification of F(ab')(2) fragment from anti hepatoma mouse IgG(1) mAb. World J Gastroenterol (1999) 0.78
The use of monoclonal antibodies raised against a human IgE myeloma paraprotein for the study of allergen extracts and sera from allergic patients. Clin Exp Immunol (1987) 0.75
Common idiotypes expressed on human, monoclonal, abnormal immunoglobulins and cryoglobulins with polyreactive autoantibody activities. Clin Exp Immunol (1993) 0.75
Acquired protein S deficiency: correlation with advanced disease in HIV-1-infected patients. J Acquir Immune Defic Syndr (1992) 1.67
Control of flagellar wave movement in Crithidia oncopelti. Nature (1975) 1.60
Characterization of the platelet membrane glycoprotein abnormalities in Bernard-Soulier syndrome and comparison with normal by surface-labeling techniques and high-resolution two-dimensional gel electrophoresis. J Clin Invest (1982) 1.50
ICAM-1 deficiency reduces atherosclerotic lesions in double-knockout mice (ApoE(-/-)/ICAM-1(-/-)) fed a fat or a chow diet. Arterioscler Thromb Vasc Biol (2000) 1.47
Increase in the adhesion molecule P-selectin in endothelium overlying atherosclerotic plaques. Coexpression with intercellular adhesion molecule-1. Am J Pathol (1994) 1.42
Systemic but not renal production of prostacyclin is highly reduced in cyclosporin-treated heart transplant recipients. Am J Cardiol (1993) 1.39
Bisphosphonates inhibit prostate and breast carcinoma cell adhesion to unmineralized and mineralized bone extracellular matrices. Cancer Res (1997) 1.39
Identification of a new congenital defect of platelet function characterized by severe impairment of platelet responses to adenosine diphosphate. Blood (1992) 1.31
Effects of calcium on flagellar movement in the trypanosome Crithidia oncopelti. J Exp Biol (1976) 1.31
A simple and efficient method for platelet isolation from their plasma. Thromb Res (1980) 1.26
Identification on human CD36 of a domain (155-183) implicated in binding oxidized low-density lipoproteins (Ox-LDL). Arterioscler Thromb Vasc Biol (1996) 1.25
The cell adhesion molecule CD31 is phosphorylated after cell activation. Down-regulation of CD31 in activated T lymphocytes. J Biol Chem (1992) 1.24
Pseudomembranous colitis probably due to rifampicin. Lancet (1980) 1.22
Absence of platelet membrane glycoproteins IIb/IIIa from monocytes. J Exp Med (1985) 1.20
Rapid purification and partial characterization of human platelet glycoprotein IIIb. Interaction with thrombospondin and its role in platelet aggregation. J Biol Chem (1989) 1.18
Identification of a domain (155-183) on CD36 implicated in the phagocytosis of apoptotic neutrophils. J Biol Chem (1996) 1.14
A monoclonal antibody (LYP18) directed against the blood platelet glycoprotein IIb/IIIa complex inhibits human melanoma growth in vivo. Blood (1989) 1.14
Glycoproteins of platelet membranes from Glanzmann's thrombasthenia. A comparison with normal using carbohydrate-specific or protein-specific labelling techniques and high-resolution two-dimensional gel electrophoresis. Eur J Biochem (1981) 1.13
CD36 peptides enhance or inhibit CD36-thrombospondin binding. A two-step process of ligand-receptor interaction. J Biol Chem (1992) 1.11
Thrombolysis with intravenous rtPA in a series of 100 cases of acute carotid territory stroke: determination of etiological, topographic, and radiological outcome factors. Stroke (1998) 1.08
Controlled trial of platelet anti-aggregating agents and subcutaneous heparin in prevention of postoperative deep vein thrombosis in high risk patients. Haemostasis (1975) 1.06
Thrombospondin-1 and -2 messenger RNA expression in normal, benign, and neoplastic human breast tissues: correlation with prognostic factors, tumor angiogenesis, and fibroblastic desmoplasia. Cancer Res (1997) 1.05
Additive antitumor activities of taxoids in combination with the bisphosphonate ibandronate against invasion and adhesion of human breast carcinoma cells to bone. Int J Cancer (1999) 1.02
Vascular biology of CD36: roles of this new adhesion molecule family in different disease states. Thromb Haemost (1997) 1.00
Thrombospondin induces dimerization of membrane-bound, but not soluble CD36. Thromb Haemost (1997) 0.99
Increase of platelet thromboxane A2 formation and of its plasmatic half-life in diabetes mellitus. Thromb Res (1980) 0.99
Monoclonal antibodies against platelet membrane glycoproteins. Characterization and effect on platelet function. Eur J Biochem (1983) 0.99
[Letter: Cholostatic jaundice caused by carbimazole]. Nouv Presse Med (1973) 0.97
Inhibition of platelet functions by a monoclonal antibody (LYP20) directed against a granule membrane glycoprotein (GMP-140/PADGEM). Blood (1991) 0.97
The effect of recombinant factor VIIa (NovoSeven) in healthy volunteers receiving acenocoumarol to an International Normalized Ratio above 2.0. Blood Coagul Fibrinolysis (1998) 0.97
Complex formation of human thrombospondin with osteonectin. Eur J Biochem (1988) 0.96
Anticardiolipin antibodies and giant cell arteritis: a prospective, multicenter case-control study. Groupe de Recherche sur l'Artérite à Cellules Géantes. Arthritis Rheum (1998) 0.96
Thrombocytopenia, macrothrombocytopathia, nephritis and deafness. Am J Med (1976) 0.95
Presence of cytoadhesins (IIb-IIIa-like glycoproteins) on human metastatic melanomas but not on benign melanocytes. Am J Clin Pathol (1989) 0.95
Activation of Ras/Raf protects cells from melanoma differentiation-associated gene-5-induced apoptosis. Cell Death Differ (2006) 0.94
Decorin inhibits cell attachment to thrombospondin-1 by binding to a KKTR-dependent cell adhesive site present within the N-terminal domain of thrombospondin-1. J Cell Biochem (1997) 0.94
Characterization of two murine monoclonal antibodies (P10, P12) directed against different determinants on human blood platelet thrombospondin. Eur J Biochem (1986) 0.94
Additional platelet membrane glycoprotein abnormalities in Glanzmann's thrombasthenia: A comparison with normals by high resolution two-dimensional polyacrylamide gel electrophoresis. Thromb Res (1980) 0.93
Metabolic-inflammatory changes, and accelerated atherosclerosis in HIV patients: rationale for preventative measures. Curr Med Chem (2008) 0.93
Impact of different low-dose ritonavir regimens on lipids, CD36, and adipophilin expression. Clin Pharmacol Ther (2008) 0.93
Human melanoma cell lines differ in their capacity to release ADP and aggregate platelets. Br J Haematol (1994) 0.92
Characterization of an anti-thrombospondin monoclonal antibody (P8) that inhibits human blood platelet functions. Normal binding of P8 to thrombin-activated Glanzmann thrombasthenic platelets. Eur J Biochem (1988) 0.91
Identification of an immunodominant functional domain on human CD36 antigen using human-mouse chimaeric proteins and homologue-replacement mutagenesis. Biochem J (1995) 0.90
Identification of human platelet glycoproteins in SDS-polyacrylamide gels using 125I labelled lectins. Thromb Res (1979) 0.90
Inhibition of AP-1 by SARI negatively regulates transformation progression mediated by CCN1. Oncogene (2010) 0.90
Isolation of thrombospondin released from thrombin-stimulated human platelets by fast protein liquid chromatography on an anion-exchange Mono-Q column. J Chromatogr (1984) 0.89
Inhibition of platelet aggregation and thromboxane synthesis after intake of small amount of icosapentaenoic acid. Thromb Res (1984) 0.89
Activated factor X cleaves factor VIII at arginine 562, limiting its cofactor efficiency. J Thromb Haemost (2009) 0.89
The vitronectin receptor (alpha v beta 3) is implicated, in cooperation with P-selectin and platelet-activating factor, in the adhesion of monocytes to activated endothelial cells. Biochem J (1994) 0.89
A radioimmunoassay for thrombospondin, used in a comparative study of thrombospondin, beta-thromboglobulin and platelet factor 4 in healthy volunteers. Thromb Res (1983) 0.89
Role of lipoxygenase products in platelet function: relation to fatty acid modified phospholipids. Adv Exp Med Biol (1985) 0.88
The dialogue between endothelial cells and monocytes/macrophages in vascular syndromes. Curr Pharm Des (2007) 0.88
Thrombospondin in milk, other breast secretions, and breast tissue. Semin Thromb Hemost (1987) 0.87
Immunization by bovine thrombin used with fibrin glue during cardiovascular operations. Development of thrombin and factor V inhibitors. J Thorac Cardiovasc Surg (1993) 0.87
Two human melanoma cell-line variants with enhanced in vivo tumor growth and metastatic capacity do not express the beta 3 integrin subunit. Eur J Biochem (1994) 0.87
Platelets and aging. I--Aggregation, arachidonate metabolism and antioxidant status. Thromb Res (1988) 0.86
Protein-S, a vitamin K-dependent protein, is a bone matrix component synthesized and secreted by osteoblasts. Endocrinology (1992) 0.86
Oxidized low-density lipoprotein induces the expression of P-selectin (GMP140/PADGEM/CD62) on human endothelial cells. Biochem J (1995) 0.86
Population pharmacokinetics of recombinant factor VIIa in volunteers anticoagulated with acenocoumarol. Thromb Haemost (1998) 0.86
A comparison of the major platelet membrane glycoproteins from Bernard-Soulier syndrome with normals after radiolabelling of sialic acid or terminal galactose/N-acetylgalactosamine residues. Thromb Res (1980) 0.86
Studies on platelet glycoproteins in Glanzmann's thrombasthenia using 125I-labelled lectins. Br J Haematol (1980) 0.86
Micromanipulation of the flagellum of Crithidia oncopelti. I. Mechanical effects. J Exp Biol (1974) 0.86
Tandem purification of mouse IgM monoclonal antibodies produced in vitro using anion-exchange and gel fast protein liquid chromatography. J Chromatogr (1986) 0.86
Antiprothrombinase and factor II deficiency in a non SLE patient. Thromb Haemost (1981) 0.86
Localization of platelet osteonectin at the internal face of the alpha-granule membranes in platelets and megakaryocytes. Blood (1992) 0.85
Cell attachment and fibrinogen binding properties of platelet and endothelial cell thrombospondin are not affected by structural differences in the 70 and 18 kDa protease-resistant domains. FEBS Lett (1988) 0.85
Cloning of the cDNA encoding human platelet CD36: comparison to PCR amplified fragments of monocyte, endothelial and HEL cells. Thromb Haemost (1993) 0.84
Description of 10 new mutations in platelet glycoprotein IIb (alphaIIb) and glycoprotein IIIa (beta3) genes. Platelets (2001) 0.84
Open trial of intravenous tissue plasminogen activator in acute carotid territory stroke. Correlations of outcome with clinical and radiological data. Stroke (1996) 0.84
Lipoxygenase activity of intact human platelets. Prostaglandins Leukot Med (1984) 0.83
Expression and localisation of alphav integrins in human odontoblasts. Cell Tissue Res (2005) 0.83
Acute hyperglycaemia induces changes in the transcription levels of 4 major genes in human endothelial cells: macroarrays-based expression analysis. Thromb Haemost (2002) 0.83
Senescent human neutrophil binding to thrombospondin (TSP): evidence for a TSP-independent pathway of phagocytosis by macrophages. Br J Haematol (1998) 0.83
Distribution of thrombospondin and integrin alpha V in DCIS, invasive ductal and lobular human breast carcinomas. Analysis by electron microscopy. Virchows Arch (1995) 0.83
New families of adhesion molecules play a vital role in platelet functions. Immunol Today (1990) 0.83
Platelet membrane glycoprotein abnormalities in patients with myeloproliferative disorders and secondary thrombocytosis. Br J Haematol (1985) 0.83
Identification of two distinct regions within the binding sites for fibrinogen and fibronectin on the IIb-IIIa human platelet membrane glycoprotein complex by monoclonal antibodies P2 and P4. Eur J Biochem (1986) 0.82
Characterization of two vaccinia CD36 recombinant-virus-generated monoclonal antibodies (10/5, 13/10): effects on malarial cytoadherence and platelet functions. Eur J Biochem (1997) 0.82
Platelet-melanoma cell interaction is mediated by the glycoprotein IIb-IIIa complex. Blood (1989) 0.82
Effect of naftazone on in vivo platelet function in the rat. Platelets (1999) 0.82
A monoclonal antibody directed against a granule membrane glycoprotein (GMP-140/PADGEM, P-selectin, CD62P) inhibits ristocetin-induced platelet aggregation. Br J Haematol (1996) 0.82